Genmab A/S

ABVANTEC

Pharmaceutical preparations and substances for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases;

ABVENTEC

Pharmaceutical preparations and substances for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases;

DUOBODY

Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases;Biochemicals, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases;Patent exploitation, namely, patent licensing ; licensing of intellectual property in the field of medicine;Medical and scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies;

DUOBODY

The word DuoBody and top/right half of the circle is black, the bottom/left half of the circle is grey.;Pharmaceutical [ and veterinary ] preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to treatment of cancer, infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases;DUO BODY;The color(s) black and grey is/are claimed as a feature of the mark.;[ Chemical, ] biochemical, biological and biotechnological preparations, especially antibodies, and bi and multi specific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these, all for vitro and in vivo scientific and industrial research and development with regard to diseases;Legal services in the form of patent exploitation and licensing of intellectual property in the field of medicines;Medical, scientific and biological research, especially research into antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies, bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these;

EPTRIOR

Pharmaceutical preparations and substances for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases;The term EPTRIOR in the mark has no meaning in a foreign language.;

GENBRIA

Pharmaceutical preparations and substances for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases;The term GENBRIA in the mark has no meaning in a foreign language.;

GENMAB

monoclonal antibody therapeutic pharmaceuticals for use in the treatment of cancer, acquired immune deficiency syndrome (AIDS), and other infectious diseases, autoimmune diseases, and cardiovascular diseases;[ biochemicals; namely, monoclonal antibodies for in vitro or scientific research regarding cancer, acquired immune deficiency syndrome (AIDS), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ];

GENMAB

Medical scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS, acquired immune deficiency syndrome, and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, namely, patent licensing; licensing of intellectual property in the field of medicine; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies;

HUMAX

Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ];Chemicals used in industry and science, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ];

HUMAX-CD20

Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases;HUMAX-CD 20;Chemicals used in industry, science namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases;

HUMAX-CD4

Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases;HUMAX-CD FOUR;Chemicals used in industry, science namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases;

KYSO

Pharmaceutical and veterinary preparations, including pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to diseases;Chemical, biochemical, biological, and biotechnological preparations, especially antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals;Patent exploitation and licensing of intellectual property in the field of medicine;Medical, scientific and biological research, especially research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these;

KYSO ANTIBODIES

Pharmaceutical and veterinary preparations, including pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to diseases;Chemical, biochemical, biological, and biotechnological preparations, especially antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals;Patent exploitation and licensing of intellectual property in the field of medicine;Medical, scientific and biological research, especially research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these;

KYSO ANTIBODY MEDICINES

Pharmaceutical and veterinary preparations, including pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to diseases;Chemical, biochemical, biological, and biotechnological preparations, especially antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals;Patent exploitation and licensing of intellectual property in the field of medicine;Medical, scientific and biological research, especially research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these;

MY NAVCARE BY GENMAB

Educational services, namely, conducting educational programs regarding patient support programs and financial assistance for healthcare; Educational services, namely, providing instructions regarding disease management and navigation through medical treatments; providing online publications, namely, brochures, written articles and guidebooks in the field of medical information and patient support;MY NAV CARE BY GENMAB;Financial administration of patient reimbursement and patient financial assistance programs; Financial administration of health reimbursement arrangements; Charitable services, namely, providing financial support to disadvantaged patients; Financial administration of medication reimbursement programs and services; Providing counseling and consulting in the field of healthcare insurance benefits; Providing healthcare insurance administration; Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; Healthcare insurance services, namely, benefit verification services, insurance authorization support and information; Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical treatments;Business administration of patient reimbursement programs; Business administration of medication reimbursement programs and patient support programs; Provision of consumer information in the field of patient reimbursement and medical benefit support; business consultation services consisting of the registration, collection, transcription, compilation and systematization of data; Business administrative services for medical referrals;Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support; Providing personal support services for families of patients with life threatening disorders, namely, companionship, help with medical forms, emotional counseling and emotional support;Medical services; medical assistance; provision of health care information; provision of information relating to medical services; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients; Consultancy in the field of the medical treatment of cancer, autoimmune diseases, and inflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields; health care services, namely, disease management programs; medical and pharmaceutical consultation; medical services, namely, provision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients;

PROTEMBOR

In the heading, delete class 5.;Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases * none of the aforesaid goods for use in dentistry, orthodontics or dental healthcare *;In the heading, class 5 reinstate Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases none of the aforesaid goods for use in dentistry, orthodontics or dental healthcare;Biochemicals, namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases;

UNIBODY

Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infections diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases;Biochemicals, namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases;Medical and scientific research, namely biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, namely, patent licensing; licensing of intellectual property in the field of medicine; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies;

VENZIOV

Pharmaceutical preparations and substances for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases;The term VENZIOV in the mark has no meaning in a foreign language.;